Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: Effects of fluoxetine and MK-801

@article{Farley2012IncreasedEO,
  title={Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: Effects of fluoxetine and MK-801},
  author={S{\'e}verine Farley and Sylvie Dumas and Salah El Mestikawy and Bruno Giros},
  journal={Neuropharmacology},
  year={2012},
  volume={62},
  pages={503-517}
}
View on Elsevier
doi.org
48 Citations
Background Citations
17
Methods Citations
1
Results Citations
3

Figures from this paper

48 Citations

Citation Type

Citation Type

Both chronic treatments by epothilone D and fluoxetine increase the short‐term memory and differentially alter the mood status of STOP/MAP6 KO mice
TLDR
It is demonstrated that STOP KO mice could represent a useful model to study the relationship between cytoskeleton, mood, and stress, and to test innovative mood treatments, such as microtubule‐stabilizing compounds.
Differential expression of VGLUT3 in laboratory mouse strains: Impact on drug‐induced hyperlocomotion and anxiety‐related behaviors
TLDR
Investigation of strain differences in VGLUT3 expression levels and its potential correlates with anxiety and reward‐guided behaviors highlights the fact that one single gene polymorphism could not account for VGLut3 expression variations, and that region specific VGL UT3 expression level variations might play a key role in the modulation of discrete behaviors.
Changes in the Prefrontal Glutamatergic and Parvalbumin Systems of Mice Exposed to Unpredictable Chronic Stress
TLDR
It is hypothesized that chronic stress-induced enhancement of glutamatergic transmission in the PFC is a crucial contributing factor to changes within the prefrontal GABAergic and, specifically, PV system, and is associated with sex-specific changes in the mRNA expression of the NR2B subunit of the NMDA receptor.
Glutamatergic mechanisms associated with stress-induced amygdala excitability and anxiety-related behavior
Higher susceptibility of somatostatin 4 receptor gene-deleted mice to chronic stress-induced behavioral and neuroendocrine alterations
Contribution of CB2 receptors in schizophrenia-related symptoms in various animal models: Short review
Donepezil and the alpha-7 agonist PHA 568487, but not risperidone, ameliorate spatial memory deficits in a subchronic MK-801 mouse model of cognitive impairment in schizophrenia
Fluoxetine modulates hippocampal cell signaling pathways implicated in neuroplasticity in olfactory bulbectomized mice
Distribution of Aquaporin-4 channels in hippocampus and prefrontal cortex in mk-801-treated balb/c mice
TLDR
The distribution of AQP-4 channels in the prefrontal cortex and hippocampus in a mouse model of NMDA receptor blocking agent-induced schizophrenia-like behavior model and there was remarkable damage in neurons and glial cells is described.
Glutamate presynaptic vesicular transporter and postsynaptic receptor levels correlate with spatial memory status in aging rat models
...
...

References

SHOWING 1-10 OF 106 REFERENCES
Hypofunctional glutamatergic neurotransmission in the prefrontal cortex is involved in the emotional deficit induced by repeated treatment with phencyclidine in mice: Implications for abnormalities of glutamate release and NMDA–CaMKII signaling
Genetic Inactivation of the NMDA Receptor NR2A Subunit has Anxiolytic- and Antidepressant-Like Effects in Mice
TLDR
Results show a selective and robust reduction in anxiety- and depression-related behavior in NMDA receptor NR2A subunit KO mice, and provide insight into the role of glutamate in the pathophysiology and treatment of mood and anxiety disorders.
Evidence for increased expression of the vesicular glutamate transporter, VGLUT1, by a course of antidepressant treatment
TLDR
Immunoautoradiography analysis showed that repeated antidepressant drug treatment increased VGLUT1 protein expression, a key gene involved in the regulation of glutamate secretion, and data suggest that a course of antidepressant drug or ECS treatment increases expression of V GLUT1.
Imipramine and phenelzine decrease glutamate overflow in the prefrontal cortex—a possible mechanism of neuroprotection in major depression?
Drug-Dependent Requirement of Hippocampal Neurogenesis in a Model of Depression and of Antidepressant Reversal
Blockade of CRF1 or V1b receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression
TLDR
Results point to an important role of CRF and AVP in the regulation of dentate neurogenesis, and suggest that CRF1 and V1b receptor antagonists may affect plasticity changes in the hippocampal formation, as do clinically effective antidepressants.
Selective cortical VGLUT1 increase as a marker for antidepressant activity
Norepinephrine and serotonin alterations following chronic stressor exposure: Mouse strain differences
Corticolimbic Transcriptome Changes are State-Dependent and Region-Specific in a Rodent Model of Depression and of Antidepressant Reversal
TLDR
These studies established on a large-scale that the molecular impacts of antidepressants are region-specific and state-dependent, revealed common transcriptional changes downstream from different antidepressant treatments and supported CRF1 targeting as an effective therapeutic strategy.
Effect of acute and chronic MK-801 administration on extracellular glutamate and ascorbic acid release in the prefrontal cortex of freely moving mice on line with open-field behavior.
...
...